Stress Leads to Contrasting Effects on the Levels of Brain Derived Neurotrophic Factor in the Hippocampus and Amygdala by Lakshminarasimhan, Harini & Chattarji, Sumantra
Stress Leads to Contrasting Effects on the Levels of Brain
Derived Neurotrophic Factor in the Hippocampus and
Amygdala
Harini Lakshminarasimhan, Sumantra Chattarji*
National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India
Abstract
Recent findings on stress induced structural plasticity in rodents have identified important differences between the
hippocampus and amygdala. The same chronic immobilization stress (CIS, 2h/day) causes growth of dendrites and spines in
the basolateral amygdala (BLA), but dendritic atrophy in hippocampal area CA3. CIS induced morphological changes also
differ in their temporal longevity- BLA hypertrophy, unlike CA3 atrophy, persists even after 21 days of stress-free recovery.
Furthermore, a single session of acute immobilization stress (AIS, 2h) leads to a significant increase in spine density 10 days,
but not 1 day, later in the BLA. However, little is known about the molecular correlates of the differential effects of chronic
and acute stress. Because BDNF is known to be a key regulator of dendritic architecture and spines, we investigated if the
levels of BDNF expression reflect the divergent effects of stress on the hippocampus and amygdala. CIS reduces BDNF in
area CA3, while it increases it in the BLA of male Wistar rats. CIS-induced increase in BDNF expression lasts for at least 21
days after the end of CIS in the BLA. But CIS-induced decrease in area CA3 BDNF levels, reverses to normal levels within the
same period. Finally, BDNF is up regulated in the BLA 1 day after AIS and this increase persists even 10 days later. In contrast,
AIS fails to elicit any significant change in area CA3 at either time points. Together, these findings demonstrate that both
acute and chronic stress trigger opposite effects on BDNF levels in the BLA versus area CA3, and these divergent changes
also follow distinct temporal profiles. These results point to a role for BDNF in stress-induced structural plasticity across both
hippocampus and amygdala, two brain areas that have also been implicated in the cognitive and affective symptoms of
stress-related psychiatric disorders.
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Introduction
Accumulating evidence indicates that the same behavioral
stress, such as 10 days of chronic immobilization stress (2 hours/
day), can elicit contrasting patterns of structural plasticity in the rat
hippocampus and amygdala simultaneously [1–3]. In addition to
being essential components of the neural circuitry mediating stress
responses, these two brain areas have also been implicated in the
cognitive and affective symptoms of stress-related psychiatric
disorders [4,5]. Earlier studies revealed that repeated or chronic
stress causes dendritic atrophy in CA3 pyramidal neurons of the
rodent hippocampus [6]. In the basolateral amygdala (BLA), by
contrast, chronic stress triggers the opposite effect by strengthening
the structural basis of synaptic connectivity through dendritic
growth and spinogenesis [3]. Stress-induced dendritic remodeling
in these two brain areas differ not only in polarity, but also in
terms of their temporal persistence. For instance, exposure to 10
days of chronic immobilization stress elicits dendritic hypertrophy
in BLA principal neurons that lasts till at least 21 days after the
termination of stress [7]. Hippocampal CA3 atrophy, on the other
hand, is reversible within the same period of post-stress recovery
[1,7]. Interestingly, the unique temporal features of stress-induced
changes in the BLA are not limited to chronic stress alone. The
temporal pattern of structural plasticity in the BLA can also be
modulated by the duration of the stressor. A much shorter
duration of the same stress, such as a single 2 h episode of
immobilization, that fails to affect spine density or dendritic
arborization one day later, leads to a significant increase in spine
density ten days later [8]. Together, these studies have helped
identify novel features of stress-induced plasticity in the amygdala
that are quite distinct from those observed in the hippocampus.
Although little is known about molecular mechanisms under-
lying these contrasting effects of stress, previous studies in the
hippocampus provide valuable leads. For example, the same
chronic stress that elicits hippocampal dendritic atrophy also
reduces levels of the neurotrophin brain-derived neurotrophic
factor (BDNF) in the rodent hippocampus [9,10]. Conversely,
chronic administration of antidepressants prevents stress-induced
decrease in BDNF levels and dendritic atrophy in the hippocam-
pus [9,11]. Together these and other findings have contributed to
the ‘‘neurotrophic hypothesis’’, which states that symptoms
associated with stress-related disorders such as depression are a
result of decreased neurotrophic support, and conversely, that
increasing neurotrophic support would lead to the correction of
these symptoms [12,13]. This hypothesis has received support
from several studies including a report that direct BDNF infusion
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30481into the rodent hippocampus produces antidepressant effects
[14,15]. Also, transgenic overexpression of the neurotrophin
BDNF has antidepressant effects and prevents chronic stress-
induced hippocampal atrophy in mice [16]. Interestingly, in the
same transgenic mice, overexpression of BDNF also causes
spinogenesis in the BLA. Moreover, BLA spinogenesis is also
triggered by chronic stress in control mice but is occluded by
BDNF overexpression, thereby suggesting a role for BDNF
signaling in stress-induced plasticity in the amygdala. These
findings, in turn, are consistent with the significant body of
evidence establishing a role for BDNF as a potent regulator of
morphological plasticity of dendrites in various brain regions [17].
Therefore, in the present study we test the prediction that if BDNF
plays a key role in stress-induced structural plasticity across both
hippocampus and amygdala, then the divergent effects of stress
should also be manifested as differential patterns of BDNF
expression in these two brain areas.
Materials and Methods
Animals
Eight week-old (adult) male Wistar rats (National Centre for
Biological Sciences, Bangalore, India) were housed in groups of 2
or 3 in a standard 14 h light and 10 h dark schedule (lights on at
7:00 A.M) with ad libitum access to food and water. All animal care
and experimentation procedures were approved by the Institu-
tional Animal Ethics Committee, National Centre for Biological
Sciences (Approval No: SC-5/2009) and Committee for the
Purpose of Control and Supervision of Experiments on Animals,
Government of India (Registration No: 109/CPCSEA).
Stress protocol and experimental design
The behavioral stress protocol has been described elsewhere
[3,7,8]. Briefly, rats were randomly assigned to experimental groups
– controls or different intensities of stress. Rats were subjected to
chronic immobilization stress (CIS) or acute immobilization stress
(AIS). Subsequently random subsets of the stressed rats were allowed
to recover for 21 days from CIS and 10 days from AIS. Stress
consisted of complete immobilization for 2 h per day (between 10
AMandnoon)inrodentimmobilizationbagswithoutaccesstoeither
food or water, for 10 consecutive days in case of CIS (CIS+1d) and a
subset of these rats were allowed to recover for 21 days (CIS+21d)
(Figure 1A and 2A). AIS consisted of a single immobilization session
of 2 h, after which either 1 day (AIS+1d) or 10 days (AIS+10) of
recovery later animals were sacrificed (Figure 3A). Day 1 marks the
beginning of the experiment while arrow indicates the end point.
Body weights
The net change in weights of rats between the beginning and
end points of the experiments was divided by the starting weight
and multiplied by 100 to calculate percentage gain in body
weights.
Corticosterone measurements
Rats were weighed and sacrificed by rapid decapitation under
deep anesthesia (halothane) and trunk blood was collected within 3
minutes for each animal; all samples were collected between 10
AM and 1 PM. Samples were centrifuged at 16000 rcf for 5 min at
4uC, and serum was stored at 280uC. Serum corticosterone level
was determined by using Correlate - EIA kit according to the
manufacturer’s instructions (Assay designs). Absorbance at 405 nm
was determined by microplate reader (Biorad). Corticosterone
concentration (ng/ml) was determined using the standard curve.
Anesthesia, decapitation and blood collection was conducted
rapidly (within 39) in an adjacent room in order to minimize stress
effects and keep the time to blood collection standardized.
Tissue collection and BDNF measurements
Basolateral amygdala (BLA) was micro dissected from 400 mm
thick coronal sections obtained from McIlwain Tissue Chopper.
Area CA3 was dissected from 400 mm thick transverse hippocampal
sections obtained using the chopper (Figure 1A). Tissue was lysed in
the presence of protease inhibitor cocktail (Roche). BDNF was
estimatedusingBDNFEmaximmunoassaykit (Promega)according
to manufacturer’s protocol. Protein levels were estimated using
BCA kit (Pierce). Levels of BDNF were normalized to protein levels.
Data analysis
Percentage changes in body weight gain were compared
between control and experimental groups using unpaired
Student’s t test assuming unequal variances. Corticosterone
measurements and BDNF data were analyzed using unpaired
Student’s t test assuming unequal variances in the case of CIS and
CIS+21d. In case of corticosterone measurements for AIS and
AIS+10d, Kruskal–Wallis test followed by Mann–Whitney post-hoc
test with Bonferroni’s adjustment was used because the data
distributions called for a non-parametric analysis. For the analysis
Figure 1. Chronic stress regulates BDNF expression in CA3 and
BLA in contrasting manner. Data are presented as mean 6 SEM. A
Experimental design of chronic stress (CIS+1d) followed by micro
dissection of area CA3 from transverse hippocampal sections or BLA
from coronal sections. B BDNF expression in area CA3 is decreased after
chronic stress (Control, n=5; CIS+1d, n=5), C Chronic stress up
regulates BDNF expression in BLA (Control, n=6; CIS+1d, n=8). Chronic
stress induced changes in BDNF expression profile is normalized to
respective control level. D Serum corticosterone levels are up regulated
after chronic stress in comparison to controls (Control, n=5; CIS+1d,
n=6). Significant differences *, p,0.05; Unpaired, two-tailed, Student’s
t-test was used to compare stress and control groups.
doi:10.1371/journal.pone.0030481.g001
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least significant difference (LSD) test was used for pairwise
comparison in the case of AIS and AIS+10d. P-values less than
0.05 were considered significant.
Results
Chronic stress elicits opposite effects on BDNF levels in
the BLA and area CA3
As described above, chronic immobilization stress (CIS; 2 h/day
for 10 days) leads to contrasting patterns of dendritic remodeling
in the BLA versus hippocampal area CA3. Specifically, 1 day after
the termination of stress, the same CIS that caused dendritic
atrophy in the CA3 pyramidal neurons, elicited dendritic growth
and spinogenesis in the BLA principal neurons. As BDNF
promotes dendritic and spine growth [18], we reasoned that the
levels of BDNF expression may reflect the divergent effects of
chronic stress on neuronal morphology in the BLA versus area
CA3. To test this prediction, we conducted ELISA analysis on
tissue micro-dissected from these two brain regions in control and
CIS treated rats (Figure 1A). There was significantly lower levels of
BDNF protein in the area CA3 1 day after chronic stress (Control,
1.0060.11; n=5; CIS+1d, 0.4360.07; data normalized to control
animals; n=5, P,0.05; Figure 1B). In striking contrast, the same
chronic stress led to significantly higher levels of BDNF protein in
the BLA 1 day later (Control, 1.0060.01; n=6; CIS+1d,
1.4460.15; data normalized to control animals; n=8; P,0.05;
Figure 1C). Thus, these data indicate that similar to its differential
effects on dendritic arborization, CIS also modulates BDNF levels
in the area CA3 and BLA in contrasting fashion.
We also confirmed the efficacy of our CIS paradigm by
assessing two widely used indicators of stress. First, we measured, 1
day after the end of the 10 day CIS protocol, the blood serum
levels of corticosterone, a common indicator of HPA axis
activation. There was a significant increase in the levels of
corticosterone in CIS animals relative to control animals (Control,
83.8642.2 ng/ml of serum; n=5; CIS+1d, 338.2694.8 ng/ml of
serum; n=6; P,0.05; Figure 1D). Second, we compared changes
in body weight (Table 1) and found a significant reduction in the
percentage weight gained 1 day after CIS (Control, 30.2661.37%;
n=12; CIS+1d, 14.461.94%; n=12; P,0.05).
Recovery after chronic stress fails to reverse elevated
levels of BDNF in the BLA, but not in area CA3
Earlier studies have reported that the impact of chronic stress
also differs between the hippocampus and amygdala in terms of its
temporal persistence. For instance, dendritic hypertrophy in the
BLA persists even after 21 days of stress-free recovery following 10
days of CIS. On the other hand, CIS-induced hippocampal CA3
atrophy is reversible within the same 21-day period of recovery.
Since the data presented so far indicates that the CIS-induced
increase and decrease in BDNF levels parallels BLA hypertrophy
and CA3 atrophy respectively, we tested if the temporal profile of
BDNF levels during post-stress recovery also differ in the two
regions. Twenty one days after the end of CIS, we found no
difference in BDNF levels in area CA3 between control and CIS
animals (Control, 1.0060.15; n=6; CIS+21d, 1.0060.2; data
normalized to control animals; n=6; P.0.05; Figure 2B). In the
Figure 3. Acute stress modulates BDNF profile differentially in
CA3 and BLA. Data are presented as mean 6 SEM. A Experimental
design of acute stress (AIS+1d) and recovery for 10 days from acute
stress (AIS+10d). B BDNF expression in area CA3 in response to acute
stress. Acute stress does not change the BDNF levels in CA3 (Control,
n=9; AIS+1d, n=9; AIS+10d, n=6, F(2,21)=2.11, p.0.05). C Acute stress
up regulates BDNF expression in BLA and this up regulation persists
even after recovery (Control, n=6; AIS+1d, n=5; AIS+10d, n=6,
F(2,14)=4.82, p,0.05). BDNF expression profile was normalized to
respective control levels and evaluated by Fisher’s post-hoc. D Effect of
acute stress and recovery from acute stress on serum corticosterone
levels (Control, n=11; AIS+1d, n=5; AIS+10d, n=6, Kruskal-Wallis
ANOVA, x
2
(2)=10.01, p,0.05, Mann-Whitney post-hoc, p,0.05). Signif-
icant differences *, p,0.05.
doi:10.1371/journal.pone.0030481.g003
Figure 2. Contrasting profiles of BDNF in CA3 and BLA in
response to recovery from chronic stress. Data are presented as
mean 6 SEM A Experimental design of 21 days of recovery from
chronic stress paradigm (CIS+21d). B BDNF expression in area CA3
comes back to control levels post recovery from chronic stress (Control,
n=6; CIS+21d, n=6), C Chronic stress induced up regulation in BDNF
expression in BLA persists even after twenty one days of recovery
(Control, n=4; CIS+21d, n=6). BDNF expression profile is normalized to
respective control level. D The up regulation of serum corticosterone
levels persists even after recovery from chronic stress (Control, n=7;
CIS+21d, n=6). Significant differences *, p,0.05; Unpaired, two-tailed,
Student’s t-test was used to compare stress and control groups.
doi:10.1371/journal.pone.0030481.g002
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even after the same post-CIS recovery period (Control,
1.0060.02; n=4; CIS+21d, 2.360.49; data normalized to control
animals; n=6; P,0.05; Figure 2C). Thus, unlike CA3 area, CIS-
induced up-regulation of BDNF protein levels in the BLA persists
up to 21 days after the end of stress.
We also monitored the impact of CIS on blood serum levels of
corticosterone and relative gain in body weight after the same
recovery period. Corticosterone levels remained elevated even 21
days after CIS (Control, 43.0611.7 ng/ml of serum; n=7;
CIS+21d, 146.3634.9 ng/ml of serum; n=6; P,0.05;
Figure 2D). In contrast, there was no difference in the percentage
gain in body weight between stressed and unstressed animals after
the recovery period (Control, 73.4164.1%; n=4; CIS+21d,
70.063.5% n=6 P.0.05) (Table 1).
Acute stress also differs in its impact on BDNF expression
over time in the BLA and area CA3
The results described so far show that BDNF levels in area CA3
and BLA, following exposure to CIS, are strikingly different both
in terms of the direction and time course of change. In contrast to
the robust effects seen when the 2 h immobilization stress is
repeated for 10 consecutive days, only a single episode of the same
stress (acute immobilization stress or AIS) is known to trigger a
different temporal pattern of changes in the BLA. Unlike CIS, AIS
fails to affect spine density or dendritic arborization, when
measured 1 day later. However, the same AIS leads to a gradual
increase in spine density 10 days later in the BLA. Therefore, next
we examined if AIS modulates BDNF levels in the hippocampus
and amygdala over time. We found only a modest reduction in
BDNF in area CA3 that was not statistically significant either 1 or
10 days after AIS (Control, 1.0060.11; n=9; AIS+1d, 0.7360.05;
data normalized to control animals; n=9; AIS+10d, 1.0260.19;
data normalized to control animals; n=6; P.0.05; Figure 3B).
However, the same AIS caused a significant increase in BDNF
levels in the BLA 1 day later (Control, 1.0060.06; n=6; AIS+1d,
2.3160.24; data normalized to control animals; n=5; P,0.05;
Figure 3C). Moreover, this AIS-induced elevation in BDNF levels
persisted in the BLA even after 10 days (CTR, 1.0060.06; n=6;
AIS+10d, 1.9860.46; data normalized to control animals; n=6;
P,0.05; Figure 3C). These findings demonstrate that even a
shorter duration of stress triggers changes in BDNF in the BLA
and CA3 area that differ considerably in their direction and
temporal features.
Since the AIS paradigm is expected to be less severe compared
to CIS, we also monitored its impact on serum levels of
corticosterone and body weight gain at the same time points after
AIS when BDNF protein levels were measured. Relative to
controls, AIS caused a significant increase in corticosterone levels
1 day later (Control, 83.8626.0 ng/ml of serum; n=11, AIS+1d,
594.76221.2 ng/ml of serum n=5 P,0.05; Figure 3D). 10 days
after AIS, corticosterone levels continued to remain high, although
the difference was no longer statistically significant (Control,
83.8626.0 ng/ml of serum; n=11; AIS+10d, 232.9678.9 ng/ml
of serum; n=6; P.0.05). Further, unlike CIS, AIS did not cause
any significant change in the percentage of body weight gain 1 day
later (Control, 1.3160.31%; n=6; AIS+1d, 0.9360.41%; n=5;
P.0.05) (Table 1). This absence of any effect on body weight was
also seen after 10 days (Control, 30.2661.37%; n=12; AIS + 10d,
17.3765.39%; n=6; P.0.05) (Table 1). Taken together, it is only
1 day after CIS that we observed a significant effect of stress on
body weight gain.
Discussion
This study explored two key facets of stress-induced modulation
of BDNF expression in the hippocampus and amygdala – one in
terms of region-specific differences, and the other in the temporal
domain. Because BDNF regulates dendritic architecture and
spines, both major targets of stress-induced structural plasticity, we
hypothesized that the levels of BDNF expression would reflect the
divergent effects of stress on the hippocampus and amygdala. To
test this hypothesis, we used two very different paradigms of
immobilization stress – an acute paradigm involving a single 2 h
session (AIS) and a chronic version wherein the same 2-hour stress
was repeated for 10 consecutive days (CIS). First, we tested
whether chronic stress elicits changes in BDNF protein levels that
parallel the contrasting patterns of dendritic remodeling observed
previously in the amygdala and hippocampus. We report that the
same CIS has strikingly opposite effects on BDNF expression one
day after the end of CIS – it reduces BDNF in area CA3, while it
increases BDNF in the BLA. This contrasting modulation was
accompanied by a significant up-regulation in circulating cortico-
sterone levels. Second, in light of earlier reports on the unique
temporal features of structural plasticity elicited in the amygdala
by both chronic and acute stress, we tested whether changes in
BDNF levels also exhibit distinct patterns across time in the two
areas. We find that not only does CIS elevate BDNF levels in the
BLA, but this increase lasts for at least 21 days after the end of
CIS, which is consistent with earlier findings on CIS-induced
dendritic hypertrophy in the BLA persisting for the same duration
after stress. In area CA3, however, CIS-induced decrease in
BDNF levels reverses to normal levels within the same post-stress
period of 21 days. This in turn is consistent with the previously
reported reversal of CA3 dendritic atrophy over the same time
frame. However, levels of corticosterone remain elevated even
after 21 days of recovery from stress. Finally, even acute
immobilization stress (AIS) modulates BDNF expression differen-
tially in the two brain areas. Exposure to AIS caused a trend in
lower BDNF levels in the CA3 area one day later, but neither was
this decrease statistically significant nor did it last for 10 days post-
stress. In contrast, the same AIS caused a more robust increase in
BDNF levels in the BLA that remained significantly above control
levels even 10 days after AIS. Interestingly, according to an earlier
study, AIS led to a delayed increase in BLA spine-density that was
manifested 10 days, but not 1 day after AIS. However, we find the
highest levels of BDNF in the BLA 1 day after AIS. Ten days after
AIS, the BLA continues to express significantly higher levels of
BDNF, albeit at levels that are lower than the 1-day time point.
Thus, AIS appears to trigger a rise in BDNF relatively soon after
stress that precedes the gradual build-up in spine-density in the
BLA. Future studies will be necessary to examine if this initial peak
Table 1. Summary of body weight measures.
Experimental group Control Stress p value
Mean 6 SEM n Mean 6 SEM n
CIS 30.361.4% 12 14.461.9% 12 0.00*
CIS+21d 73.464.1%; 4 70.063.5% 6 0.54
AIS 1.360.3% 6 0.960.4% 5 0.38
AIS+10d 30.361.4% 12 17.465.4%; 6 0.07
Data are presented as mean 6 SEM. Significant differences.
*, p,0.05; Unpaired, two-tailed, Student’s t-test was used to compare stress and
control groups.
doi:10.1371/journal.pone.0030481.t001
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that eventually culminates in delayed BLA spinogenesis 10 days
later.
The contrasting effects of stress on BDNF shed new light on
earlier findings on the differential patterns of cellular changes
elicited by chronic and acute stress in the amygdala versus
hippocampus. Both in terms of the direction and temporal profile
of these changes, the enhanced levels of BDNF elicited by chronic
stress parallels the profile of dendritic growth and spinogenesis in
the BLA. These findings are also significant in view of an earlier
study demonstrating that transgenic overexpression of BDNF
enhances spine-density in the BLA of mice [16]. BLA spinogenesis
is also elicited by chronic stress. Importantly, transgenic over-
expression of BDNF occludes chronic stress induced spinogenesis
in the BLA. Together these findings suggest a role for BDNF in
stress-induced structural plasticity in the amygdala. The results
reported here also add to the earlier studies on region-specific
differences showing stress-induced increase in BDNF expression in
the hypothalamus [19] and the nucleus acumbens (NAc) [20]
compared to decreased levels in the hippocampus. Further, the up-
regulation of BDNF seen in the NAc after social-defeat stress
persists for as long as 4 weeks, similar to the prolonged increase we
see in the BLA [20]. The upregulation of BDNF reported earlier in
the hypothalamic paraventricular nucleus occurs in response to
both single 2 h as well as chronic 7 days of immobilization stress
[19]. On the other hand, chronic stress-induced reduction of
BDNF levels, and its reversal during stress-free recovery, mirrors
earlier findings on reversible dendritic atrophy elicited by chronic
stress in hippocampal area CA3. However, short episodes of acute
stress lasting 15 min or 60 min induces a transient increase in
BDNF mRNA levels in the hippocampus which is in sharp con-
trast to the decrease in BDNF mRNA expression seen in response
to longer stress [21]. Together, these findings also highlight the
importance of investigating the potential mechanisms that cause
the same stress to have opposite effects on BDNF expression as
well as the differential impact of variable durations of stress on
BDNF levels.
Exposure to stressful events leads to glucocorticoid release by
the activation of the hypothalamic–pituitary–adrenal (HPA) axis.
The temporal profile of changes in corticosterone profile shows an
initial rise 1 day after AIS which decreases 10 days later and
returns to levels that are not significantly different from control
levels. Thus, the variations in corticosterone levels reported here
appear to depend on both the severity of the stress paradigm and
time points of measurement after the termination of stress. Our
observations are broadly consistent with earlier reports showing
that the output of the HPA axis is influenced by the periodicity,
intensity and degree of habituation of the stressor [22–26]. The
reduction in hippocampal BDNF due to acute and chronic stress,
in turn, is known to be mediated at least in part by stress-induced
increase in glucocorticoids [10,27]. Yet the same increase in
corticosterone appears to be associated with enhanced BDNF
levels in the BLA. Stress also leads to significant increase in
extracellular levels of glutamate in the hippocampus and amygdala
[28–30]. This suggests that although some of the immediate
consequences of stress – elevated glucocorticoids and glutamate –
are similar in both brain areas, they subsequently lead to
contrasting patterns of BDNF expression and structural plasticity.
This implies that signaling mechanisms more downstream of the
initial changes in glucocorticoids and glutamate, but upstream of
BDNF, may hold the key to the differential impact of stress in
these brain areas. Importantly BDNF infusion into the hippocam-
pus of stressed rodents helped to protect against the deleterious
effects of stress despite high levels of circulating corticosterone
[31]. This suggests that BDNF could be a final point of
convergence for the stress induced effects in the hippocampus.
BDNF-mediated signaling is involved in stress response but the
direction and nature of signaling is region-specific, stress specific
and is influenced by epigenetic modifications along with post
translational modifications [32]. Thus, brain region specific
variations in BDNF expression is a key question that requires
further investigation. Moreover, a complex balance is maintained
in BDNF-driven neuronal plasticity, based on the competition
between BDNF-TrkB system and pro-BDNF-p75 system [33].
Interestingly, activation of TrkB and p75NTR promote and
suppress dendritic spine growth respectively [33]. Since the
findings presented here do not distinguish between TrkB and
p75NTR, which are known to have opposing biological functions,
future studies will be necessary to elucidate the impact of stress on
these different forms in different brain regions.
What may be the functional consequences of the divergent
effects of stress on BDNF in the hippocampus and amygdala?
Growing evidence has linked growth of dendrites and spines in
the BLA – caused either by stress or BDNF overexpression – to
enhanced anxiety-like behavior [8,15]. This is relevant in light of
our results showing that the same time points when stress triggers
higher anxiety is also when BDNF is elevated in the BLA. For
instance, both anxiety and BDNF are increased 1 and 21 days
after CIS. Interestingly, BDNF mRNA has been shown to be
elevated transiently in the BLA 2 hours after cued fear
conditioning and such a temporally restricted elevation of BDNF
signaling is believed to be a key step in the formation of a cue-
specific fear [34,35]. In contrast, a more sustained up-regulation
of BDNF in the BLA may underlie the pathological increase in
fear and anxiety observed following stress [16]. Hippocampal
memory and synaptic plasticity also depend on BDNF, and
reduced levels of BDNF following chronic stress is consistent with
a large body of evidence showing impairment of hippocampal
function and loss of hippocampal volume caused by stress [36–
39]. Further as hippocampal BDNF is critically involved in
resilience to stress, any reduction can enhance vulnerability to
stress [40]. Therefore, the opposite effects on BDNF in the
amygdala and hippocampus may provide a molecular basis for
the contrasting behavioral effects of stress on memories encoded
by these two brain areas. Moreover, these two brain areas differ
not only in their response to stress, but also in how they regulate
the stress response. While the hippocampus exerts a negative
feedback regulation of the stress response via the HPA axis, the
amygdala has the opposite effect [41]. Therefore, the differential
effects on BDNF in these two brain regions following stress could
lead to an imbalance in HPA axis function through a gradual loss
of hippocampal inhibitory control as well as a gain in excitatory
control exerted by the amygdala. The regional differences in the
pattern of BDNF expression triggered by stress also pose a
significant challenge for pharmacological interventions aimed at
countering the effects of stress on the amygdala and hippocam-
pus. Therefore, elucidation of the mechanisms behind the
differential effects of stress on BDNF in the hippocampus and
amygdala is likely to provide useful insights into novel therapeutic
interventions against stress-related psychiatric disorders that are
characterized by impaired cognitive function and abnormally
high fear and anxiety.
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